IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BELLONE, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.203
EU - Europa 302
AS - Asia 245
OC - Oceania 1
SA - Sud America 1
Totale 1.752
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.190
CN - Cina 136
UA - Ucraina 114
IT - Italia 51
SG - Singapore 49
DE - Germania 39
FI - Finlandia 33
HK - Hong Kong 32
IE - Irlanda 17
TR - Turchia 17
RU - Federazione Russa 15
GB - Regno Unito 13
CA - Canada 12
IN - India 8
FR - Francia 7
BE - Belgio 3
CZ - Repubblica Ceca 2
NL - Olanda 2
SE - Svezia 2
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 1.752
Salva come PNG Salva come JPEG
Città #
Fairfield 180
Woodbridge 158
Houston 109
Ashburn 89
Jacksonville 76
Wilmington 72
Ann Arbor 68
Seattle 66
Cambridge 62
Dearborn 43
Singapore 40
Nanjing 34
New York 34
Chandler 32
Hong Kong 32
Princeton 30
Helsinki 18
Dublin 17
Istanbul 16
Beijing 14
Shanghai 13
Toronto 12
Moscow 11
Shenyang 11
Nanchang 8
San Diego 8
Des Moines 7
Kunming 7
Los Angeles 6
Milan 6
Hebei 5
Jiaxing 5
Jinan 5
Ningbo 5
Brescia 4
Rome 4
Tianjin 4
Arezzo 3
Brussels 3
Changsha 3
Hangzhou 3
Hefei 3
Kilburn 3
Monmouth Junction 3
Auburn Hills 2
Boardman 2
Chongqing 2
Guangzhou 2
Lanzhou 2
Leawood 2
Pavia 2
Romola 2
Salò 2
Taizhou 2
Zhengzhou 2
Amman 1
Amsterdam 1
Bishkek 1
Boston 1
Brno 1
Chicago 1
Colombo 1
Indiana 1
Kocaeli 1
London 1
Luxembourg 1
Melbourne 1
Minsk 1
Mountain View 1
Mumbai 1
Munich 1
Nanning 1
New Bedfont 1
Norwalk 1
Olomouc 1
Orange 1
Providence 1
Quanzhou 1
Redmond 1
San Francisco 1
San José 1
Sofia 1
Taiyuan 1
Verona 1
Vienna 1
Walnut 1
Zhangzhou 1
Totale 1.386
Salva come PNG Salva come JPEG
Nome #
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 149
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 141
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. 133
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas 129
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. 125
Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab. 114
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 112
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 112
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody 111
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor 106
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor 100
Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcomas cell lines is linked to tubulin-beta-III expression. 99
Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 97
Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2) 97
Serum amyloid A: a novel biomarker for endometrial cancer. 71
Integrated mutational landscape analysis of uterine leiomyosarcomas 37
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 31
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 23
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 8
Expression of αV-integrins in uterine serous papillary carcinomas; implications for targeted therapy with intetumumab (CNTO 95), a fully human antagonist anti-αV-integrin antibody. 2
Totale 1.797
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.263
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020316 0 0 0 0 0 81 53 57 42 48 9 26
2020/2021263 5 29 10 27 8 23 42 28 33 24 26 8
2021/2022155 24 34 0 2 1 11 11 6 4 22 14 26
2022/2023138 22 3 3 6 13 27 5 16 18 0 13 12
2023/2024173 13 11 20 4 8 38 13 5 33 6 1 21
2024/2025101 1 4 2 37 22 35 0 0 0 0 0 0
Totale 1.797